Physico-chemical characterization of small molecules, peptides, proteins and phytopharmaceuticals Development of oral, nasal and injectable formulations Exploring new approaches in dosage form development to meet unmet medical needs

• March 2020 -Present:
  Assistant Professor, NIPER- Ahmedabad, Palaj, Gandhinagar
• May 2017 - March 2020:
  Manager 1, - Formulation Research & Development,Sun Pharmaceutical Industries Ltd.Vadodara
• March 2015 – May 2017:
  Scientist E2 (Pharmaceutics) ,Corporate Research & Development Centre, HLL Lifecare Ltd.,Thiruvananthapuram,Kerala.
• March 2012 - March 2015:
  Research Officer ,– Formulation Development, Sun Pharma Advanced Research Company Ltd.Mumbai.

Awards

• BUDDING NANOTECHNOLOGIST AWARD for oral presentation entitled "Modified nanoprecipitation approach for the design of polymer-lipid hybrid nanoparticles (LIPOMER) of doxorubicin hydrochloride” at the Third Winter School on Nanotechnology in Advanced Drug Delivery held at National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, February 8th-12th, 2010.
• FIRST PRIZE FOR POSTER PRESENTATION entitled "Role of lipid in the design of polymer-lipid hybrid nanoparticles (LIPOMER) of doxorubicin hydrochloride by modified nanoprecipitation method” at 10th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems organized by Controlled Release Society- Indian Chapter held at Mumbai, February 17th-18th, 2010.
• Awarded Senior Research Fellowship by University Grants Commission (UGC) for the Ph.D.
• Awarded Junior Research Fellowship by UGC for M. Pharm
• Travel Grant, International Liposome Research Days (LRD) and Lipids, Liposomes & Membrane Biophysics (LLMB) conference (LIPOSOMES 2010), University of British Columbia, Vancouver, British Columbia, Canada - 2010, Awarded by Department of Biotechnology (DBT). Ministry of Science & Technology, Government of India

• Dhwani Rana, Sagar Salave, Derajram Benival. (2021). Emerging trends in Abuse-Deterrent Formulations: Technological insights and Regulatory considerations, Current Drug Delivery. DOI : 10.2174/1567201818666211208101035
• Dhwani Rana, Sagar Salave, Suraj Longare, Rishabh Agarwal, Kiran Kalia, Benival D.M. (2021). Nanotherapeutics in Tumour Microenvironment for Cancer Therapy, Nanoscience & Nanotechnology-Asia. DOI : 10.2174/2210681211666210908144839
• Sagar Salave, Sonali Jain, Ambika Chamoli, Amit Mandoli, Ravi Shah, Kiran Kalia,Benival D.M,. (2020). Role Of Biologicals For Combating Covid-19: A Systematic Review, World Journal Of Pharmacy And Pharmaceutical Sciences,9(12), 456-484. DOI: 10.20959/wjpps202012-17770
• Benival D.M, and Devarajan Padma V. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. International Journal of Pharmaceutics. 2012;423: 554–561 (Impact Factor: 4.213).
• Benival D.M, and Devarajan Padma V. In situ lipidization as a new approach for the design of a self microemulsifying drug delivery system (SMEDDS) of doxorubicin hydrochloride for oral administration. Journal of Biomedical Nanotechnology. 2014; 10:1-10 ((Impact Factor: 5.068).